Matt Tuttle can't quite pronounce the name of Eli Lilly's (LLY) oral weight-loss drug, but that doesn't stop him from understanding its significance to the healthcare company's future. He reacts to the increased attention on the overall sector and compares LLY to other names like Hims & Hers (HIMS). Later, Tom White composes a put vertical example options strategy for LLY.